Biofil Chemicals & Pharmaceuticals Limited — Board Meeting, 11-08-2026: Outcome of Board Meeting
11-08-2026 | 06:24 pm
11-08-2026 | 06:24 pm
Biofil Chemicals & Pharma's board approved Q1 financial results. Revenue hit ₹12.35 Cr, Net Profit ₹0.11 Cr, EPS ₹0.07. Also, Mr. Ashok Kumar Ramawat continues as an Independent Director, and the 41st AGM is set for September 23.
No comments yet. Be the first to comment!
All announcements from Biofil Chemicals & Pharmaceuticals Limited
